HELPING PATIENTS
LIVE HEALTHY LIVES
THROUGH SIGNIFICANT
STROKE REDUCTION

Three large clinical studies confirm the superiority of PFO closure to medical management in reducing the risk of stroke recurrence.

THE TURNING POINT FOR PFO CLOSURE

The turning point for pfo closure

*Not reported
See important safety information referenced within.

References:

  1. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017; 377: 1022-32.
  2. Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017; 377: 1033-42.
  3. Mas J-L, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017;377:1011-21 and supplementary appendix. 5. Lee PH, Song J-K, Kim JS, et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial, Journal of the American College of Cardiology (2018), doi: 10.1016/j.jacc.2018.02.046.